Bookimed does not add extra charges for Hodgkin's lymphoma treatment prices. The rates come from the clinics' official price lists. You pay directly at the clinic for your treatment upon your arrival to the country.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Hodgkin's lymphoma treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Hodgkin's lymphoma treatment journey.
| Turkey | Austria | Spain | |
| Radiation therapy for colorectal cancer | from $3,250 | - | from $3,629 |
| Chemotherapy for breast cancer | from $1,200 | - | from $1,037 |
| Chemotherapy | from $3,000 | - | from $1,037 |
| Biological therapy | from $2,000 | - | - |
| Immunotherapy with Keytruda (Pembolizumab) | from $7,300 | - | from $12,798 |
Hospital Sant Joan de Déu (Barcelona, Spain) accepts children for treatment from the infant age to 21. The Hospital belongs to Top-5 medical institutions in Europe and is recognized as the most authoritative one in the field of pediatric oncology treatment. The Center has its own Laboratory for Molecular Medicine where innovative therapeutic methods are developed.
Clinic HM Nou Delfos is a comprehensive medical-surgical center in Barcelona, which is a part of the largest network in Spain – HM Hospitals. HM Delfos specializes in surgery, oncology, orthopedics, cardiology, gynecology, urology, neurology including diagnosis and treatment of epilepsy. The clinic is equipped with the very latest devices for diagnostics and treatment: EOS for high-precision images of the musculoskeletal system, CT and MRI, two units for radiotherapy of tumors without surgery.
The clinic has also the agreement with Institut Guttmann, neurorehabilitation hospital with JCI, AQU Catalunya, and ISO quality certificates for rehabilitation.
Professor Bosch is a highly reputed leader in Chronic Lymphocytic Leukemia (CLL) and conducts clinical and basic research on CLL and other lymphoproliferative disorders, focusing on the molecular pathogenesis of CLL and new therapeutic approaches. He has published over 100 articles in prestigious journals and is a professor of haematology at the Vall d'Hebron University Hospital of Barcelona.